Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
04/2003
04/01/2003US6541019 Preservatives of formulations for topical use
04/01/2003US6541016 Monoalkyl phosphoric esters, dialkyl phosphoric esters, and, in small amounts, trialkyl phosphoric esters or salts, based on beta-branched fatty alcohols, effective in lowering the surface tension of both polar and nonpolar liquids
04/01/2003US6541015 Water soluble prodrug with a biologically active agent link trapped in a hydrogel and controllably released by diffusion
04/01/2003US6541001 A stable compacted, compressed or hard tableted vaccine formulation containing a freeze dried antigenic component and a dissolution aid
04/01/2003US6541000 Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response
04/01/2003US6540983 A drug selected from an insulin analog, and/or amylin, a fluid propellant carrier, and a stabilizer comprising water added in addition to nascent formulation water; treating diabetes; inhalers
04/01/2003US6540980 Method of detecting endometriosis
04/01/2003US6540393 Apparatus for preparing microparticles using in-line solvent extraction
04/01/2003CA2405918A1 Controlled release macrolide pharmaceutical formulations
04/01/2003CA2317785C Liniment for topical application
04/01/2003CA2270975C Stabilized sustained release tramadol formulations
04/01/2003CA2163539C N-morpholino-n-nitrosaminoacetonitrile cyclodextrin inclusion complexes
03/2003
03/28/2003CA2357982A1 Solid compositions comprising ramipril
03/27/2003WO2003025125A2 Selective substrates for matrix metalloproteinases
03/27/2003WO2003025062A1 Polymeric hydrogel
03/27/2003WO2003025002A2 Method and compositions of defensin-antigen fusion proteins and chemokine-antigen fusion proteins as vaccines for tumors and viral infection
03/27/2003WO2003024952A1 Bioprecursors for percutaneous application
03/27/2003WO2003024477A1 Method for delivery of molecules to intracellular targets
03/27/2003WO2003024475A1 Water-insoluble sustained release compositions, preparations thereof and process for producing the same
03/27/2003WO2003024466A1 Liquid preparation containing crude-drug extract
03/27/2003WO2003024455A2 Stent coated with a sustained-release drug delivery and method for use thereof
03/27/2003WO2003024454A2 Topical composition containing brucine and the use for the treatment of damaged mammalian skin
03/27/2003WO2003024452A1 Novel medicaments for inhalation
03/27/2003WO2003024449A1 Pharmaceutical formulations for protecting pharmaceutical compound from acidic environments
03/27/2003WO2003024438A1 Composition comprising cysteamine for improving lactation in dairy animals
03/27/2003WO2003024433A2 Compositions for treatment of common cold, comprising ipratropium and xylometazoline
03/27/2003WO2003024428A1 Amino acid modulated extended release dosage form
03/27/2003WO2003024425A1 Nanoparticulate insulin formulations
03/27/2003WO2003024423A1 Apoptosis-mimicking synthetic entities and use thereof in medical treatment
03/27/2003WO2003024422A1 Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entities
03/27/2003WO2003024421A2 Triclosan dosage form
03/27/2003WO2003024420A1 Ophthalmic depot formulations for periocular or subconjunctival administration
03/27/2003WO2003024396A2 Dry powder medicament formulations
03/27/2003WO2003024392A2 Compositions and methods for the diagnosis and treatment of tumor
03/27/2003WO2003024360A1 Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
03/27/2003WO2003024357A2 Microfabricated nanopore device for sustained release of therapeutic agent
03/27/2003WO2003002149A3 Use of pigment such as e.g. titanium dioxide for obtaining a special optical effect on oral medicament or food
03/27/2003WO2003000237A3 Biodegradable polymer coompositions
03/27/2003WO2002102311A3 Nanoparticles for treating targeted tissues and cells
03/27/2003WO2002092054A3 Immune modulation device for use in animals
03/27/2003WO2002074332A3 Method to enhance the immunogenicity of an antigen
03/27/2003WO2002062393A3 Coating for orally administered compositions
03/27/2003WO2002059291A3 Biological organism for preparing pharmaceutical compositions for treating mammals
03/27/2003WO2002055544A3 Fibrin binding polypeptides useful inter alia in medical imaging processes
03/27/2003WO2002055100A3 Method and composition for inhibition of tumor growth and enhancing an immune response
03/27/2003WO2002054868A3 Pulmonary delivery of polyene antifungal agents
03/27/2003WO2002053190A3 Particles for inhalation having sustained release properties
03/27/2003WO2002053100A3 Pharmaceutical dosage form for oral administration of low molecular weight heparin
03/27/2003WO2002053089A3 Stable skin conditioning compositions containing retinoid boosters
03/27/2003WO2002049552A3 Solution for removing cataracts via liquefracture
03/27/2003WO2002043806A3 In vivo delivery methods and compositions
03/27/2003WO2002038170A3 Stabilized inteferon compositions
03/27/2003WO2002026220A3 Taxoid conjugates as antimitotic and antitumor agents
03/27/2003WO2002026212A3 Microparticle compositions and methods for the manufacture thereof
03/27/2003WO2002017962A9 Chemoprotectant for gastric toxicity
03/27/2003WO2002017880A3 Nitric oxide-producing hydrogel materials
03/27/2003WO2002007767A3 Pharmaceutical suspension compositions lacking a polymeric suspending agent
03/27/2003WO2002004006A3 Method for improving the efficacy of artificial insemination of non-human animals
03/27/2003WO2001097865A3 Multiple phase cross-linked compositions and uses thereof
03/27/2003WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents
03/27/2003WO2001070685A3 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
03/27/2003US20030060606 Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
03/27/2003US20030060559 Thermally reversible water in oil in water emulsions
03/27/2003US20030060493 Kit comprising a pharmaceutical composition containing repinotan or a physiologically acceptable salt of repinotan, and a means for the determination of the concentration of repinotan or its metabolites in body
03/27/2003US20030060486 Liquid formulations for the prevention and treatment of mucosal diseases and disorders
03/27/2003US20030060483 Method of increasing pharmaceutical market
03/27/2003US20030060479 Compositions and medical device for transdermal delivery of a drug and methods of making and using same
03/27/2003US20030060427 Dissolving an organic compound having a lactone nucleus in lower alcohol and water; antitumor agents
03/27/2003US20030060404 Storage stability, long shelf life; a solution has anti-microbial activity without additional anti-microbial agent; growth hormones for cats and dogs; veterinary medicine
03/27/2003US20030060402 Novel cyclosporin galenic forms
03/27/2003US20030060381 Dispersion comprising a non-ionic emulsifier
03/27/2003US20030059937 Antibodies that immunospecifically bind BLyS
03/27/2003US20030059912 Hybrid ptorin for use in treating allergies and controlling immunogical response
03/27/2003US20030059865 Oligo(ethylene glycoll)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers
03/27/2003US20030059841 Methods of using bioelastomers
03/27/2003US20030059840 Methods of using bioelastomers
03/27/2003US20030059773 Immunomodulatory formulations and methods for use thereof
03/27/2003US20030059472 Preparation of submicron sized nanoparticles via dispersion lyophilization
03/27/2003US20030059470 Dispersions for the formulation of slightly or poorly soluble agents
03/27/2003US20030059469 Protecting the carboxylic acid group of the drug molecule, adding to the drug molecule a chlorinated polyanhydride linker, deprotecting by exposing the linked drug molecules to heat or vacuum, acetylating to produce monomer, polymerizing
03/27/2003US20030059468 Preparations and processes for stabilizing biological materials by means of drying processes without freezing
03/27/2003US20030059465 Stabilized nanoparticle formulations of camptotheca derivatives
03/27/2003US20030059462 Dissolving a powder of liposome-forming lipids in an organic solvent to a level close to saturation, adding to the solute obtained a dry, water immiscible carotenoid to obtain a suspension, drying and dehydrating the powder obtained
03/27/2003US20030059461 Molecular delivery vehicle for delivery of selected compounds to targets
03/27/2003US20030059458 Encapsulated carob fibers having improved product properties, process for production thereof and use thereof
03/27/2003US20030059456 Intravaginal drug delivery devices for the administration of an antimicrobial agent
03/27/2003US20030059446 Physically stable sprayable gel composition
03/27/2003US20030059440 Composition and method for moisturizing nasal tissue
03/27/2003US20030059401 Composition and method for causing photodynamic damage to target cells
03/27/2003US20030059398 Water-soluble stabilized self-assembled polyelectrolytes
03/27/2003US20030059397 Solid oral dosage forms of controlled substances having reduced potential for abuse by inhalation, mastication, and injection; for alternative administration of oxycodone
03/27/2003US20030059380 Inhomogeneous silicas as carrier material
03/27/2003US20030059376 Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
03/27/2003US20030059370 In vivo diagnostic apparatus and methods thereof
03/27/2003US20030059368 Chelator noncovalently bonded to a stable isotope having a nucleus capable of capturing a neutron and emitting a photon, a counterion and a buffer; measuring glomerular filtration rate and glomerular sieving function in a subject
03/27/2003CA2708411A1 Compositions and methods for the diagnosis and treatment of tumor
03/27/2003CA2708349A1 Compositions and methods for the diagnosis and treatment of tumor
03/27/2003CA2460987A1 Pharmaceutical formulations for protecting pharmaceutical compound from acidic environments
03/27/2003CA2460885A1 Composition comprising cysteamine for improving lactation in dairy animals
03/27/2003CA2460783A1 Bioprecursors for percutaneous application
1 ... 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 ... 1712